Synergy CHC Corp.
SNYR- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0001562733
No open-market purchases or sales by Synergy CHC Corp. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $133.1K in total; no superinvestor holds it.
Other share classesSNYRQ
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +2 vs. previous quarter
- 15
- 13F valueReported value at the end of Q2 2026
- $133.1K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding SNYR, Q2 2026
No superinvestor reported holding SNYR at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Synergy CHC Corp. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 31, 2025 (view filing) | Jun 11-Jul 30 | 50 daysLate | Ross JackCEO and Chairman | PPurchaseCommon Stock, par value $0.00001 per share | +27.9K | $2.85 | +$79.6K | +7.3%410.5K after | 24 lots |
| Jun 13, 2025 (view filing) | Jun 11 | 2 days | Knight Therapeutics Inc10% Owner | PPurchase | +428.6K | $0.00 | $0 | –428.6K after | Derivative |
| Jun 11, 2025 (view filing) | Jun 2-10 | 9 daysLate | Ross JackCEO and Chairman | PPurchaseCommon Stock, par value $0.00001 per share | +16.1K | $1.85 | +$29.8K | +4.4%382.6K after | 6 lots |
| May 21, 2025 (view filing) | Apr 11-May 15 | 40 daysLate | Ross JackCEO and Chairman | PPurchaseCommon Stock, par value $0.00001 per share | +5.30K | $2.05 | +$10.9K | +1.5%366.5K after | 12 lots |
| May 21, 2025 (view filing) | Feb 21-Apr 10 | 89 daysLate | Ross JackCEO and Chairman | PPurchaseCommon Stock, par value $0.00001 per share | +14.3K | $2.74 | +$39.3K | +4.1%361.2K after | 30 lots |
| Mar 3, 2025 (view filing) | Jan 23-Feb 21 | 39 daysLate | Ross JackCEO and Chairman | PPurchaseCommon Stock, par value $0.00001 per share | +15.2K | $3.92 | +$59.5K | +4.6%346.9K after | 20 lots |
| Mar 3, 2025 (view filing) | Nov 25, 2024-Jan 22, 2025 | 98 daysLate | Ross JackCEO and Chairman | PPurchaseCommon Stock, par value $0.00001 per share | +5.17K | $4.92 | +$25.5K | +1.6%331.7K after | 30 lots |
| Oct 24, 2024 (view filing) | Oct 24 | Same day | Ross JackCEO and Chairman | PPurchaseCommon Stock, par value $0.00001 per share | +300.0K | $9.00 | +$2.70M | New position300.0K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Synergy CHC Corp. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Jane Street Group, LLC | 181,648 | $36.1K | 0.00% | +181,648 | New |
| ACT Advisors, LLC. | 151,840 | $30.1K | 0.01% | +151,840 | New |
| SOA Wealth Advisors, LLC. | 83,075 | $16.5K | 0.00% | +73,075+730.8% | Added |
| XTX Topco Ltd | 61,270 | $12.2K | 0.00% | +61,270 | New |
| Vanguard Capital Management LLC | 38,909 | $7.74K | 0.00% | −50,861−56.7% | Reduced |
| Geode Capital Management, LLC | 32,775 | $6.50K | 0.00% | +11,377+53.2% | Added |
| HRT Financial LP | 34,035 | $6.00K | 0.00% | +34,035 | New |
| Virtu Financial LLC | 18,539 | $4.00K | 0.00% | +18,539 | New |
| Vanguard Fiduciary Trust Co | 16,008 | $3.19K | 0.00% | −7,141−30.8% | Reduced |
| StoneX Group Inc. | 15,109 | $3.00K | 0.00% | +15,109 | New |